Why is Pfizer's rollout of its anti-COVID pill so slow?
In this photo provided by Pfizer, a lab technician visually inspects Paxlovid tablet samples in Freiburg, Germany in December 2021. Studies showed that the first pill to treat the virus led to a nearly 90% reduction in hospitalizations and deaths among patients most likely to get severe disease. (Pfizer via AP) Credit: thomas hansmann.fotograf/AP
Get the SBS Audio app
Other ways to listen
Pfizer's COVID-19 treatment pill Paxlovid was the first pill authoriSed in the U-S to treat coronavirus. But since its approval, there have been questions as to why it takes so long to make.
Share
